Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure.
about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failureAdiponectin, driver or passenger on the road to insulin sensitivity?Obesity, inflammation, and lung injury (OILI): the good.Effect of macronutrients, age, and obesity on 6- and 24-h postprandial glucose metabolism in catsChange in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study.Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism.Activation of host tissue trophic factors through JAK-STAT3 signaling: a mechanism of mesenchymal stem cell-mediated cardiac repair.Tissue taurine depletion alters metabolic response to exercise and reduces running capacity in mice.Cachexia in heart disease: highlights from the ESC 2010G-protein-coupled receptor kinase 2-mediated desensitization of adiponectin receptor 1 in failing heart.Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure.Adiponectin and cardiovascular health: an updateAdipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantationAdiponectin action: a combination of endocrine and autocrine/paracrine effects.Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training.The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung diseaseMolecular and cellular mechanisms of skeletal muscle atrophy: an update.Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adultsRegional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model.Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetesAdiponectin and risk of vascular events in the Northern Manhattan study.Adiponectin, diabetes and ischemic heart failure: a challenging relationship.The adipose tissue production of adiponectin is increased in end-stage renal disease.A high-fat diet decreases AMPK activity in multiple tissues in the absence of hyperglycemia or systemic inflammation in rats.Effect of physiological determinants and cardiac disease on plasma adiponectin concentrations in dogs.Adipose tissue density, a novel biomarker predicting mortality risk in older adults.Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults.Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study.Can exercise teach us how to treat heart disease?Functional adiponectin resistance and exercise intolerance in heart failure.Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.Direct effects of adipokines on the heart: focus on adiponectin.Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?Obesity, body composition and cardiorespiratory fitness in heart failure with preserved ejection fraction.Inflammation - Cause or Consequence of Heart Failure or Both?Effects of training and detraining on adiponectin plasma concentration and muscle sensitivity in lean and overweight men.The evolving role of adiponectin as an additive biomarker in HFrEF.Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.
P2860
Q26745026-B5A56300-B3F8-45E1-8F95-655B8E0C67BCQ26827971-9F2F627A-B30D-4F34-A09C-33E5F97F8DE1Q30363313-64C836A6-E00B-433C-B6BD-FF955796DB14Q33816580-AA01EB37-9F88-4439-9D35-61BB3A9AF45DQ34195243-2B7BBD2C-FE9E-4281-8304-50EFA1F5FF9BQ34234199-AC490F4C-285D-4213-A789-03867E97D436Q34357753-9479BA77-C0D4-4F7A-8A35-D6BE9D39DB40Q34588672-FE5B1CA7-7D8A-4DAE-AD2A-682685CD0E80Q34716880-607AECCE-28E2-495C-BB1B-1BF723C41A34Q35528402-83966CCF-D10A-41A4-BA7F-39FCBAB962CCQ35581324-720B4FD1-F70D-4F7D-AB40-404245DDCBD7Q35859734-5B1D7788-6B80-4638-BD21-4FA668F638A1Q35965821-D532C88D-5E40-44FD-981C-748390555785Q35971216-AC943DD2-613B-47D2-A420-26D6ED0CE04AQ36045758-FA85FC8D-E20E-4335-8553-0EDE6A3F534DQ36158231-0EBE4DA6-F22E-41D7-84E2-AED0CC72A156Q36179105-1729607C-501A-4542-BAA9-61BA8D68178FQ36508893-B9608260-9120-40BF-8047-5C25C06080D0Q36510256-B1B1E4B6-C82D-4C89-A5FA-AC4AA3C1E08CQ36513591-A88036E6-F986-40D9-9CFF-2811418A4BBDQ36537039-8059D4C6-8FB5-4D94-B585-2F935163EBFDQ36571908-498B7D53-AD35-4960-B0D2-95A0F6160839Q36654242-C93C64E7-4199-4B33-8D47-857FB8D9AC0BQ36815297-3EDED8E4-3E28-4DE6-8A17-98A2DAD3783CQ36975575-EB31CE31-6E27-43B9-B9A1-BFD53BF5821EQ37383910-C7EEBB14-A98C-4C25-A6D0-84BF2FF3AF13Q37510787-2B46E807-228D-4B5D-A097-5B0EB678FA1AQ37669742-269FC9D6-DC88-489B-A575-E13FE0DB1038Q37669745-210E2268-D2CA-476F-A58E-B0A44272CD5CQ37723852-E550F87B-82BC-44BF-82DD-FAA31D938688Q37855653-0A62A8FC-4501-46FF-ADA1-BEEC9A0FCED3Q38017586-D78ECFB1-C610-4B79-872F-8E887BD7EB9DQ38034678-0E0FD43C-5682-451D-8C13-2D0A7A13B022Q38054603-F73C7B09-B283-4BAB-9770-4D685503DD81Q38077655-893C4167-27CE-4AA6-9489-650D284EA7A8Q38644526-CC66895B-0040-475A-959C-05704ABE67E1Q38664204-5922ECCB-6A80-4DEB-98F1-939C4AAC89B6Q38820876-2A1A4179-0D58-4497-902C-D8FD5034B55BQ38915167-73CCC219-F2AA-48DE-8859-023B97F52FFAQ39408922-40DDB798-79F6-49BC-A590-A17582A08D80
P2860
Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Functional adiponectin resista ...... oderate chronic heart failure.
@en
Functional adiponectin resista ...... oderate chronic heart failure.
@nl
type
label
Functional adiponectin resista ...... oderate chronic heart failure.
@en
Functional adiponectin resista ...... oderate chronic heart failure.
@nl
prefLabel
Functional adiponectin resista ...... oderate chronic heart failure.
@en
Functional adiponectin resista ...... oderate chronic heart failure.
@nl
P2093
P50
P1476
Functional adiponectin resista ...... oderate chronic heart failure.
@en
P2093
An M Van Berendoncks
Christiaan J Vrints
Dominique Fortin
Nadine Possemiers
Vicky Y Hoymans
Wim Martinet
P304
P356
10.1161/CIRCHEARTFAILURE.109.885525
P577
2010-01-26T00:00:00Z